
FDA Grants Ustekinumab-Aekn Interchangeability Designation for Stelara
The FDA approved ustekinumab-aekn (Selarsdi) as an interchangeable biosimilar with ustekinumab (Stelara). The product is currently available and interchangeable for all indications of ustekinumab, including treatment of psoriatic arthritis, plaque …